Page 4 - While Pfizer News Today

The head of Pfizer's corporate flight department detailed the integral role his operation played in getting a Covid-19 vaccine to market.

Guru Besar Paru Fakultas Kedokteran Universitas Indonesia (FKUI) Profesor Tjandra Yoga Aditama mengemukakan ada sedikit penurunan efektivitas sejumlah vaksin Covid-19 terhadap varian B1617 saat dibandingkan dengan B117.

The Companies Tackling A Global Health Crisis FN Media Group Presents Financialmorningpost.com Market Commentary News provided by Share this article Share this article NEW YORK, May 20, 2021 /PRNewswire/ -- The global market for psychedelic drug treatments and therapy is in the early stages of what looks to be a massive shift. A growing wave of research has shown the power of psychedelics in offering effective treatments for mental health disorders such as depression, anxiety, and more.   Me...

Share: Pfizer Inc. (NYSE: PFE) and BioNTech SE - ADR (NASDAQ: BNTX) have started the process to seek full approval from the U.S. Food and Drug Administration (FDA) for a COVID-19 vaccine. What Happened: The companies’ vaccine was made accessible in the U.S. last December when the FDA issued an Emergency Use Authorization (EUA). Since then, more than 170 million doses of the vaccine have been delivered nationwide. Because the EUA is only a temporary grant, the companies have initiated a Biol...

https://www.afinalwarning.com/511711.html (Natural News) A study performed in Israel warned that the Pfizer/BioNTech COVID-19 vaccine puts people at higher risk for variants of concern. It elaborated that those who complete both doses are eight times more likely to contract the South African B1351 strain. The study also pointed out that people who received one dose of the BNT162b2 mRNA vaccine were also more susceptible to contracting the U.K. B117 variant. A team of researchers from the Tel...

Share: Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 48.7%. But there is no question some big-name stocks performed better than others along the way. BioNTech’s Big Run: One company that has been a home-run investment in the last year has been biotech stock BioNTech SE - ADR (NASDAQ: BNTX). BioNTech’s claim to fame in the past year has been its COVID-19 vaccine partn...

Government spends $24m on COVID jab ads By Shannon Jenkins Wednesday January 27, 2021 Australians can expect to see advertisements calling on them to get a COVID-19 vaccine from Wednesday, with the federal government launching its $23.9 million public information campaign across television, radio, social media and other platforms. The campaign will inform Australians of vaccine-related details, including their safety and effectiveness, and where to get the jab, according to health minister Gr...

What to Know About Johnson & Johnson’s Single-Dose COVID-19 Vaccine Prevention 3/12/2021 Korin Miller Johnson & Johnson’s single-dose COVID-19 vaccine has been authorized for emergency use by the U.S. Food and Drug Administration. On March 10, President Joe Biden announced his intent to purchase an additional 100 million doses of the Johnson & Johnson vaccine. The Johnson & Johnson vaccine was 85% effective at preventing severe or critical forms of COVID-19 28 days after ...

The world's top coronavirus vaccine drugmaker has been underperforming. I think 2021 will change that.

POLITICO U.S. could get additional Pfizer vaccine doses by summer Officials “are engaged in active negotiations” with Pfizer to boost the U.S. supply, HHS Secretary Alex Azar told reporters Wednesday morning. Dr. Michelle Chester draws the Pfizer-BioNTech COVID-19 vaccine into a syringe at Long Island Jewish Medical Center, Monday, Dec. 14, 2020, in the Queens borough of New York. (AP Photo/Mark Lennihan, Pool) | Mark Lennihan, Pool/AP Photo Updated: Link Copied The United States is negoti...